[The indomethacin treatment of glomerulonephritis patients with the urinary syndrome].
Immediate results are analyzed of the treatment of 57 glomerulonephritis patients with the urinary syndrome using indomethacin. The treatment proved effective in 65% of patients. It was established that indomethacin had no immunotropic effects in urinary syndrome. Absence of arterial hypertension is not a prognosis-positive factor for treatment of the urinary syndrome with indomethacin.
Dorets'kyĭ
V V
VV
D000293:Adolescent; D000328:Adult; D004341:Drug Evaluation; D005260:Female; D005921:Glomerulonephritis / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use*; D008297:Male; D013577:Syndrome
D007213:Indomethacin
Likuvannia indometatsynom khvorykh na hlomerulonefryt z sechovym syndromom.